US Stock MarketDetailed Quotes

PXMD PaxMedica

Watchlist
  • 0.078
  • +0.004+4.97%
15min DelayClose Dec 20 16:00 ET
845.04KMarket Cap-0.03P/E (TTM)

About PaxMedica Company

PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.

Company Profile

SymbolPXMD
Company NamePaxMedica
Listing DateAug 26, 2022
Issue Price5.25
Founded2018
CEOMr. Howard J. Weisman
MarketPink Market
Employees7
Fiscal Year Ends12-31
Address303 South Broadway,Suite 125
CityTarrytown
ProvinceNew York
CountryUnited States of America
Zip Code10591
Phone1-914-987-2876

Company Executives

  • Name
  • Position
  • Salary
  • Howard J. Weisman
  • Chief Executive Officer and Chairman of the Board
  • 1.05M
  • Stephen D. Sheldon
  • Chief Financial Officer, Principal Accounting Officer and Chief Operating Officer
  • 635.87K
  • Dr. David W. Hough, M.D.
  • Chief Medical Officer
  • 266.78K
  • Zachary Rome
  • Director
  • 322.23K
  • Charles J. Casamento
  • Lead Independent Director
  • 98.83K
  • Dr. John F. Coelho
  • Independent Director
  • 79.47K
  • Karen LaRochelle
  • Independent Director
  • 83.31K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.